comparemela.com

Research analysts at StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $8.00 price objective on shares of GlycoMimetics in a report on Thursday, August […]

Related Keywords

Chicago ,Illinois ,United States , ,Beirne Wealth Consulting Services ,Freedom Wealth Alliance ,Nasdaq ,Charles Schwab Investment Management Inc ,Northern Trust Corp ,Glycomimetics Inc ,Glycomimetics Company Profile ,Chicago Partners Investment Group ,Get Free Report ,Wealth Alliance ,Wealth Consulting Services ,Trust Corp ,Partners Investment Group ,Charles Schwab Investment Management ,Glycomimetics Daily ,Glycomimetics ,Nasdaq Glyc ,Glyc ,Medical ,Initiated Coverage ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.